362 related articles for article (PubMed ID: 11346806)
1. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
[TBL] [Abstract][Full Text] [Related]
2. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group.
Pediatr Res; 2000 Nov; 48(5):593-9. PubMed ID: 11044477
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
5. Maternal IQ, child IQ, behavior, and achievement in urban 5-7 year olds.
Chen A; Schwarz D; Radcliffe J; Rogan WJ
Pediatr Res; 2006 Mar; 59(3):471-7. PubMed ID: 16492992
[TBL] [Abstract][Full Text] [Related]
6. Primary prevention of childhood lead poisoning--the only solution.
Rosen JF; Mushak P
N Engl J Med; 2001 May; 344(19):1470-1. PubMed ID: 11346814
[No Abstract] [Full Text] [Related]
7. Do children with falling blood lead levels have improved cognition?
Liu X; Dietrich KN; Radcliffe J; Ragan NB; Rhoads GG; Rogan WJ
Pediatrics; 2002 Oct; 110(4):787-91. PubMed ID: 12359796
[TBL] [Abstract][Full Text] [Related]
8. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
10. The Treatment of Lead-exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers.
Paediatr Perinat Epidemiol; 1998 Jul; 12(3):313-33. PubMed ID: 9690266
[TBL] [Abstract][Full Text] [Related]
11. Lead poisoning prevention, not chelation (commentary).
Henretig F
J Toxicol Clin Toxicol; 2001; 39(7):659-60. PubMed ID: 11778662
[No Abstract] [Full Text] [Related]
12. Effect of succimer on growth of preschool children with moderate blood lead levels.
Peterson KE; Salganik M; Campbell C; Rhoads GG; Rubin J; Berger O; Ware JH; Rogan W
Environ Health Perspect; 2004 Feb; 112(2):233-7. PubMed ID: 14754579
[TBL] [Abstract][Full Text] [Related]
13. Chelation therapy in children exposed to lead.
Shannon M; Woolf A; Binns H
N Engl J Med; 2001 Oct; 345(16):1212-3. PubMed ID: 11642245
[No Abstract] [Full Text] [Related]
14. Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study.
Baghurst PA; McMichael AJ; Wigg NR; Vimpani GV; Robertson EF; Roberts RJ; Tong SL
N Engl J Med; 1992 Oct; 327(18):1279-84. PubMed ID: 1383818
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren: a randomized, placebo-controlled trial.
Rico JA; Kordas K; López P; Rosado JL; Vargas GG; Ronquillo D; Stoltzfus RJ
Pediatrics; 2006 Mar; 117(3):e518-27. PubMed ID: 16510631
[TBL] [Abstract][Full Text] [Related]
16. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.
Lasky RE; Laughlin NK; Luck ML
Environ Res; 2001 Sep; 87(1):21-30. PubMed ID: 11534961
[TBL] [Abstract][Full Text] [Related]
17. Succimer and the reduction of tissue lead in juvenile monkeys.
Smith DR; Woolard D; Luck ML; Laughlin NK
Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
[TBL] [Abstract][Full Text] [Related]
18. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
[TBL] [Abstract][Full Text] [Related]
19. Effect of succimer chelation therapy on postural balance and gait outcomes in children with early exposure to environmental lead.
Bhattacharya A; Shukla R; Auyang ED; Dietrich KN; Bornschein R
Neurotoxicology; 2007 May; 28(3):686-95. PubMed ID: 17499360
[TBL] [Abstract][Full Text] [Related]
20. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
Newman TB; Liljestrand P; Jeremy RJ; Ferriero DM; Wu YW; Hudes ES; Escobar GJ;
N Engl J Med; 2006 May; 354(18):1889-900. PubMed ID: 16672700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
